Doramapimod (GMP)
Product Specifications
UNSPSC Description
Doramapimod GMP (BIRB 796 GMP) is an orally active inhibitor for p38 MAPK, with IC50s of 38, 65, 200 and 520 nM, for p38α, p38β, p38γ, p38δ. Doramapimod exhibits cytotoxicity and antitumor activity against multiple myeloma, synergizes with multidrug resistance protein 1 (ABCB1) and aurora kinase inhibitor VX680, promoting their antitumor efficacy against oral epidermoid carcinoma and cervical cancer. Doramapimod also exhibits anti-inflammatory activity[1].
Target Antigen
p38 MAPK
Type
GMP Small Molecules
Related Pathways
MAPK/ERK Pathway
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/doramapimod-gmp.html
Smiles
O=C(NC1=CC(C(C)(C)C)=NN1C2=CC=C(C)C=C2)NC3=C4C=CC=CC4=C(OCCN5CCOCC5)C=C3
Molecular Weight
527.66
References & Citations
[1]Cicenas J, et al., JNK, p38, ERK, and SGK1 Inhibitors in Cancer. Cancers (Basel). 2017 Dec 21;10(1):1.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-10320G/Doramapimod-GMP-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-10320G/
Clinical Information
No Development Reported
CAS Number
285983-48-4
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
cAP-1415 1 Frozen Vial
CHO-K1/HEK293 Cells Stable expressing GPCR protein VIPR1 (Protein accession # NM_004624)
Ask
View Details 
BNC942206-100 100 µL
Anti-HSP60 (Heat Shock Protein 60) (Mitochondrial Marker) (HSPD1/2206R), CF594 conjugate
Ask
View Details 
MBS7024037-01 0.02 mg
Recombinant Gemmatimonas aurantiaca NADH-quinone oxidoreductase subunit K (nuoK)
Ask
View Details 
MBS7024037-02 0.1 mg
Recombinant Gemmatimonas aurantiaca NADH-quinone oxidoreductase subunit K (nuoK)
Ask
View Details MBS7024037-03 5x 0.1 mg
Recombinant Gemmatimonas aurantiaca NADH-quinone oxidoreductase subunit K (nuoK)
Ask
View Details